Tuesday 7 September 2021 – ACBC was proud to host the third biennial Australia China Health Summit – Online, a successful collaboration between the Australia China Business Council and the Australia China Health Accelerator with support from the National Foundation for Australia-China Relations, Global Victoria and Invion.
Our largest and most ambitious virtual offering to date, we were delighted to host 20 expert speakers with diverse backgrounds to present over 4 distinct sessions to over 120 virtual attendees from around Australia, China and further abroad.
Among heightened global tensions, an ongoing global pandemic and disrupted international trade, the health sector remains the great leveller. Ongoing bilateral health collaboration in research, biotech, MedTech, investment and more has brought with it immeasurable benefits to the business and medical communities of both Australia and China – with no signs of slowing down.
Topics addressed at the Summit ranged from opportunities in China’s vibrant Greater Bay Area to the huge potential for Chinese companies in Australia’s well-placed, and strongly supported MedTech ecosystem. Speakers shared unique knowledge and experience on engaging with China’s healthcare market from investor, MedTech and research perspectives. Esteemed keynote presentations proved cross border B2B and P2P relationships continue to drive Australia’s engagement in the region.
We were honoured to host eminent business community leaders, medical professionals and decision makers who are committed to the bilateral business relationship to speak at this Summit and we thank them for sharing their wisdom, optimism, and words of advice with our guests.
We acknowledge the support of the Victorian State Minister for Innovation, Medical Research, and the Digital Economy, The Hon. Jaala Pulford MP, Victoria’s Commissioner to China, Brett Stevens (for stepping in at the last minute when the Minister was called into Parliament) and National Foundation for Australia-China Relations Acting CEO, Gareth Williams for opening the proceedings.
Invion is developing PhotosoftTM technology as an improved next generation Photodynamic Therapy (PDT). PDT uses non-toxic photosensitisers and visible light to produce cytotoxic-reactive oxygen that kills malignant cells, shuts down tumours and stimulates the immune system. It’s a potential alternative to surgery, and unlike radiotherapy and chemotherapy, it isn’t immunosuppressive.
If you need any further information about this event, please contact email@example.com.